Skip to main content

Day: March 4, 2021

Boskalis publishes 2020 Annual Report and Sustainability Report

Papendrecht, 4 March 2021‎Royal Boskalis Westminster N.V. (Boskalis) has published both its Annual Report 2020 and its Sustainability Report 2020.As Boskalis, we contribute through our business and our activities to society and the UN Sustainable Development Goals. We do so in the areas of flood protection, creating infrastructure for trade and energy with the associated employment this generates, and advancing the energy transition to renewables.Our Sustainability Report gives information about our approach, targets and progress on sustainability.The Annual Report 2020 has been filed in accordance with the European Single Electronic Format (ESEF). Click here to download the XHTML Annual Report 2020 as a zip file. The reports are also available as interactive PDF documents and can be downloaded via www.boskalis.com/reports.FOR FURTHER...

Continue reading

Boskalis publiceert Annual Report en Sustainability Report 2020

Papendrecht, 4 maart 2021Koninklijke Boskalis Westminster N.V. (Boskalis) heeft zojuist het Annual Report 2020 gepubliceerd, alsmede het Sustainability Report 2020.Boskalis draagt met zijn activiteiten bij aan de maatschappij evenals aan de Sustainable Development Goals van de Verenigde Naties. Zo bieden wij bescherming tegen overstromingen, creëren wij infrastructuur voor handel en energie met de bijbehorende werkgelegenheid en bevorderen wij de energietransitie naar hernieuwbare energiebronnen.Het Sustainability Report geeft inzicht in onze aanpak, doelstellingen en vooruitgang op het gebied van duurzaamheid.Het Annual Report 2020 is gedeponeerd conform het European Single Electronic Format (ESEF). Klik hier om het XHTML Annual Report 2020 te downloaden als zipbestand. Daarnaast zijn de rapporten beschikbaar als interactieve PDF-documenten....

Continue reading

AIM ImmunoTech to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th

OCALA, Fla., March 04, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the H.C. Wainwright Life Sciences Conference to be held virtually between March 9-10, 2021.AIM’s presentation will be available on-demand to registered attendees via the conference platform beginning Tuesday, March 9, 2021, at 7:00 AM Eastern Time. The webcast will be accessible here, and the presentation will be available on the investor relations section of AIM’s website at https://aimimmuno.com/events-presentations/. Management will also be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.About AIM ImmunoTech Inc.AIM ImmunoTech Inc. is an immuno-pharma...

Continue reading

Burlington Stores, Inc. Reports Fourth Quarter 2020 Results

Announces New 2,000 Store TargetOn a GAAP basis, total sales increased 4%, net income was $156 million, and diluted EPS was $2.33Comparable store sales were flat, reflecting significant improvement in December and JanuaryGross Margin improved 40 basis points, driven by a 110 basis point increase in merchandise marginOn a Non-GAAP basis, Adjusted EPS was $2.44New store target increased to 2,000 stores, up from previous goal of 1,000 storesBURLINGTON, N.J., March 04, 2021 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the fourth quarter ended January 30, 2021.Michael O’Sullivan, CEO, stated, “We saw comparable store sales improve sequentially...

Continue reading

Titan Machinery Inc. to Report Fiscal Fourth Quarter and Full Year Ended January 31, 2021 Results on March 18, 2021

WEST FARGO, N.D., March 04, 2021 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the fourth quarter and full year ended January 31, 2021, on Thursday, March 18, 2021, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time).Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. International callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, April 1, 2021, by dialing (844) 512-2921 from the U.S., or (412) 317-6671 from international locations, and entering confirmation code 13716797.There also will be a simultaneous,...

Continue reading

Lands’ End Announces Participation in the D.A. Davidson 4th Annual Consumer Growth Conference

DODGEVILLE, Wis., March 04, 2021 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced that the Company will be participating in the D.A. Davidson 4th Annual Consumer Growth Conference, held virtually, on Thursday, March 11, 2021 with a fireside chat presentation at 4:15 PM Eastern Time.The audio portion of the fireside chat presentation will be webcast live over the internet and can be accessed on the investor relations section of the Company’s website at http://investors.landsend.com. An online archive will be available for a period of 90 days following the presentation.  About Lands’ End, Inc.Lands’ End, Inc. (NASDAQ:LE) is a leading uni-channel retailer of casual clothing, accessories, footwear and home products. We offer products online at www.landsend.com, on third party online marketplaces and through...

Continue reading

Repeat: Colfax Announces Intention to Separate Into Two Independent Public Companies

Will Create Focused Specialty Medical Technology and Fabrication Technology CompaniesSeparation Will Accelerate Strategic Momentum and Unlock Significant Value Creation PotentialCompany Intends Tax-Free Separation to be Completed in the First Quarter of 2022Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) —  – Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.“This is an exciting day for Colfax and an important step to unlock the full value inherent in our MedTech and FabTech businesses,” said...

Continue reading

Beam Therapeutics to Participate in the Barclays 2021 Global Healthcare Conference

CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the Barclays 2021 Global Healthcare Conference on Thursday, March 11, 2021 at 2:25 p.m. ET.The live webcast will be available in the investor section of the company’s website at www.beamtx.com. The webcast will be archived for 60 days following the presentation.About Beam TherapeuticsBeam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making...

Continue reading

PureGold Surface Exploration Drilling Intersects High Grade Gold at Three Targets Near PureGold Mine

VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (TSX-V:PGM, LSE:PUR) (“PureGold” or the “Company”), is pleased to announce that surface exploration drilling has intersected high grade gold mineralization located outside PureGold’s existing Mineral Resources1 at three distinct targets—Wedge, Treasure Box, and No. 1 Vein — as shown on the map linked below. The continued success of the ongoing surface exploration program is consistent with the Company’s objective of fueling PureGold’s future organic growth beyond the Phase 1 Mine by discovering new zones and expanding upon known zones of high grade gold across the Company’s 47km2 property. An updated mineral resource estimate is in progress and is anticipated to be published in the second quarter.Drilling results highlights:16.6 g/t gold over 5.0...

Continue reading

The RealReal Prices Offering of $250.0 Million 1.00% Convertible Senior Notes Due 2028

SAN FRANCISCO, March 04, 2021 (GLOBE NEWSWIRE) — The RealReal, Inc. (Nasdaq: REAL), the world’s largest online marketplace for authenticated, consigned luxury goods—today announced the pricing of its offering of $250.0 million in aggregate principal amount of its 1.00% Convertible Senior Notes due 2028 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering, the Company granted the initial purchasers a 13-day option to purchase up to an additional $37.5 million in aggregate principal amount of notes. The offering is expected to close on March 8, 2021, subject to customary closing conditions.The notes will be convertible into cash, shares of the Company’s common stock or a combination of cash and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.